You are here
Clinical Trials: Liver Disease
Each Clinical Trial will open in a new browser window or tab.
Condition: Acute-On-Chronic Liver Failure
Intervention: Genetic: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
Sponsor: Hai Li
Not yet recruiting
Intervention: Genetic: Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
Sponsor: Hai Li
Not yet recruiting
Condition: Fatty Liver, Nonalcoholic
Interventions: Drug: Cilostazol 50 MG; Drug: Placebo
Sponsor: Sadat City University
Recruiting
Interventions: Drug: Cilostazol 50 MG; Drug: Placebo
Sponsor: Sadat City University
Recruiting
Condition: Patients Having a Scheduled Abdominal Surgery Procedure
Interventions: Other: blood samples; Other: biopsy of abdominal paroie
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Interventions: Other: blood samples; Other: biopsy of abdominal paroie
Sponsor: Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Condition: Liver Cirrhoses
Intervention: Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell
Sponsor: PT. Prodia Stem Cell Indonesia
Recruiting
Intervention: Biological: Allogeneic Umbilical Cord Mesenchymal Stem Cell
Sponsor: PT. Prodia Stem Cell Indonesia
Recruiting
Condition: Cirrhosis, Liver
Interventions: Combination Product: CD 34 and MSC infusion; Drug: Standard of care for Cirrhosis management
Sponsor: Asian Institute of Gastroenterology, India
Recruiting
Interventions: Combination Product: CD 34 and MSC infusion; Drug: Standard of care for Cirrhosis management
Sponsor: Asian Institute of Gastroenterology, India
Recruiting
Condition: Liver Cirrhosis
Intervention: Drug: GXHPC1
Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting
Intervention: Drug: GXHPC1
Sponsor: Gwo Xi Stem Cell Applied Technology Co., Ltd.
Not yet recruiting
Condition: NASH - Nonalcoholic Steatohepatitis
Intervention: Drug: HepaStem
Sponsor: Promethera Biosciences
Recruiting
Intervention: Drug: HepaStem
Sponsor: Promethera Biosciences
Recruiting
Condition: Liver Cirrhosis
Interventions: Biological: 2 times SHED group; Biological: 4 times SHED group
Sponsors: Changhai Hospital; Eastern Hepatobiliary Surgery Hospital; CAR-T (Shanghai) Biotechnology Co., Ltd.
Not yet recruiting
Interventions: Biological: 2 times SHED group; Biological: 4 times SHED group
Sponsors: Changhai Hospital; Eastern Hepatobiliary Surgery Hospital; CAR-T (Shanghai) Biotechnology Co., Ltd.
Not yet recruiting
Condition: Decompensated Liver Cirrhosis
Interventions: Biological: umbilical cord-derived mesenchymal stem cell; Other: Comprehensive treatment
Sponsor: Beijing 302 Hospital
Recruiting
Interventions: Biological: umbilical cord-derived mesenchymal stem cell; Other: Comprehensive treatment
Sponsor: Beijing 302 Hospital
Recruiting
Condition: Acute-On-Chronic Liver Failure
Intervention: Biological: allo-APZ2-ACLF
Sponsors: RHEACELL GmbH & Co. KG; FGK Clinical Research GmbH; Ticeba GmbH
Not yet recruiting
Intervention: Biological: allo-APZ2-ACLF
Sponsors: RHEACELL GmbH & Co. KG; FGK Clinical Research GmbH; Ticeba GmbH
Not yet recruiting